{
    "organizations": [],
    "uuid": "a645800cf8f56bb4d395d1809548da59c0f7a79e",
    "author": "",
    "url": "https://www.reuters.com/article/brief-avexis-q4-loss-per-share-255/brief-avexis-q4-loss-per-share-2-55-idUSASB0C7S7",
    "ord_in_thread": 0,
    "title": "BRIEF-Avexis Q4 Loss Per Share $2.55",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 27, 2018 / 9:04 PM / Updated 11 minutes ago BRIEF-Avexis Q4 Loss Per Share $2.55 Reuters Staff Feb 27 (Reuters) - Avexis Inc: * AVEXIS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS * Q4 LOSS PER SHARE $2.55 * ‍ON TRACK TO REQUEST PRE-BLA MEETING WITH FDA IN Q2 2018​ * ‍INTENDS TO INITIATE PIVOTAL TRIAL IN SMA TYPE 1 IN EUROPE AND MULTI-NATIONAL PRE-SYMPTOMATIC SMA STUDY IN FIRST HALF OF 2018​ * ‍ANTICIPATES IND SUBMISSIONS FOR RETT SYNDROME AND GENETIC ALS IN LATE 2018/EARLY 2019​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-27T23:03:00.000+02:00",
    "crawled": "2018-02-27T23:17:38.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "avexis",
        "inc",
        "avexis",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "operating",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "track",
        "request",
        "meeting",
        "fda",
        "q2",
        "initiate",
        "pivotal",
        "trial",
        "sma",
        "type",
        "europe",
        "sma",
        "study",
        "first",
        "half",
        "ind",
        "submission",
        "rett",
        "syndrome",
        "genetic",
        "al",
        "late",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}